Pharma Two B
Signal active
Organization
Contact Information
Overview
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.
About
Industries
Biotechnology, Pharmaceutical, Biopharma
Founded
2007
Employees
1-10
Headquarters locations
Asia
Social
N/A
Profile Resume
Pharma Two B headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Biopharma sector. The company focuses on Biotechnology and has secured $912.0M in funding across 24 round(s). With a team of 1-10 employees, Pharma Two B is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Pharma Two B, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
2
Lead Investors
0
Total Funding Amount
$38.0M
Details
2
Pharma Two B has raised a total of $38.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Late Stage Venture | 30.0M | ||
| 2012 | Early Stage Venture | 8.0M |
Investors
Pharma Two B is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| JVC | - | FUNDING ROUND - JVC | 30.0M |
| JK&B Capital | - | FUNDING ROUND - JK&B Capital | 30.0M |
| Pharma Two B | - | FUNDING ROUND - Pharma Two B | 30.0M |
| Generali Financial Holding | - | FUNDING ROUND - Generali Financial Holding | 30.0M |
Recent Activity
There is no recent news or activity for this profile.